The new HIV prevention drug lenacapavir will be available as a twice-yearly injection. It will cost about $40 a year and is expected to be available in 120 low- and middle-income countries. This is a major step in fighting HIV.
However, not all countries will have access. Middle-income countries with rising HIV rates might be excluded. Campaigners say that more funding is needed for healthcare workers and for distributing this drug effectively.
Difficult words
- drug — A substance used for medical treatment.
- injection — A shot given using a needle.
- countries — Nations or areas with their own governments.
- access — The ability to use or reach something.
- funding — Money provided for a specific purpose.
- healthcare — Services related to health and medical care.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is lenacapavir considered a major step in fighting HIV?
- How do you think funding can improve healthcare services?
- What might happen if middle-income countries are excluded from access?
Related articles
Why Deforestation Causes More Heat Deaths
Researchers say stopping deforestation is important for health. Heat deaths are rising due to tree loss.
Child Marriage is a Systemic Failure
Child marriage in Pakistan is a serious issue affecting many girls, denying them their dreams and impacting their health. The article discusses the legal framework, societal challenges, and hopeful changes regarding this issue.
Rethinking Health Finance in Africa at UN Talks
African leaders aim to change health funding at UN meetings. They emphasize self-reliance and need for better local investment.
Alternative Sweetener Linked to Liver Disease
New research shows that sorbitol, a common sugar substitute, can be harmful to the liver.
Toxic Beauty: Health Risks of Latin America's Cosmetics Trade
Many cosmetics in Latin America contain harmful chemicals. They are sold without labels or safety standards, posing health risks.
Why the Wait for Newborn Malaria Treatment?
Many newborns in Africa suffered due to a lack of specific malaria treatment until now. A new drug aims to help, but questions remain about the delay.